Close menu


Press release

Advanced BioDesign announces that it has obtained funding for its CRISPALDHin project as part of the relaunch france plan

Advanced BioDesign and the Inserm TAGC laboratory will receive a total of €208,000 to support the development of their CRISPALDHin project over the next two years. CRISPALDHin project aims at developing adaptive and personalised treatments targeting multiple genomic alterations involving aldehyde dehydrogenases 1 (ALDH 1) which are at the root of cancers resistance.


Read the press release

More information